Most not long ago, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical places as classical opioid receptors, it binds to the big range of endogenous opioids. Compared with most opioid receptors, this receptor functions as being a scavenger and won't act